📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Delayed immune-related adverse events with anti-PD-1-based immunotherapy in melanoma. (2021)

First Author: Owen CN

Attributed to: Development of a 'humanised' model for renal cancer funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.annonc.2021.03.204

PubMed Identifier: 33798657

Publication URI: http://europepmc.org/abstract/MED/33798657

Type: Journal Article/Review

Volume: 32

Parent Publication: Annals of oncology : official journal of the European Society for Medical Oncology

Issue: 7

ISSN: 0923-7534